Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Childhood, adolescent and young adult non‐Hodgkin lymphoma: current perspectives
Mitchell S. Cairo, Auke Beishuizen
British Journal of Haematology (2019) Vol. 185, Iss. 6, pp. 1021-1042
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

A Summary of the Inaugural WHO Classification of Pediatric Tumors: Transitioning from the Optical into the Molecular Era
Stefan M. Pfister, Miguel Reyes‐Múgica, John K. C. Chan, et al.
Cancer Discovery (2021) Vol. 12, Iss. 2, pp. 331-355
Open Access | Times Cited: 134
Use of rituximab in mature, high-grade and advanced-stage pediatric B-lineage non-Hodgkin lymphomas: a systematic review, meta-analysis and the Brazilian reality
Alejandra Adriana Cardoso de Castro, Liana Alves de Oliveira, Diancarlos Pereira de Andrade, et al.
Frontiers in Pediatrics (2025) Vol. 13
Open Access | Times Cited: 1
Survival of European adolescents and young adults diagnosed with cancer in 2010–2014
Annalisa Trama, Laura Botta, Charles Stiller, et al.
European Journal of Cancer (2024) Vol. 202, pp. 113558-113558
Open Access | Times Cited: 6
Survival of European children, adolescents and young adults diagnosed with haematological malignancies in the period 2000-2013: results from EUROCARE-6, a population-based study
Annalisa Trama, EE Geerdes, Elena Demuru, et al.
European Journal of Cancer (2025), pp. 115336-115336
Closed Access
Rituximab in pediatric B-cell Non-Hodgkin Lymphoma: Clinical outcomes and prognostic implications
Şefika Akyol, Turan Güzel, Alper Özcan, et al.
Trends in Pediatrics (2025) Vol. 6, Iss. 1, pp. 54-61
Open Access
STAT3 couples activated tyrosine kinase signaling to the oncogenic core transcriptional regulatory circuitry of anaplastic large cell lymphoma
Nicole Prutsch, Shuning He, Alla Berezovskaya, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 3, pp. 101472-101472
Open Access | Times Cited: 4
The effectiveness and reliability of autologous hematopoietic stem cell transplantation following chemotherapy in managing malignant lymphoma: a meta-analysis
Hend Ahmed, Ahmed S. Shafiey, Mohamed E. A. Abdelrahim
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Mediastinal tumours and pseudo-tumours: a comprehensive review with emphasis on multidisciplinary approach
Maria‐Rosa Ghigna, Vincent de Montpréville
European Respiratory Review (2021) Vol. 30, Iss. 162, pp. 200309-200309
Open Access | Times Cited: 25
The Health Care Utilization and Medical Costs in Long-Term Follow-Up of Children Diagnosed With Leukemia, Solid Tumor, or Brain Tumor: Population-Based Study Using the National Health Insurance Claims Data
James S Miser, Ben‐Chang Shia, Yi‐Wei Kao, et al.
JMIR Public Health and Surveillance (2023) Vol. 9, pp. e42350-e42350
Open Access | Times Cited: 6
Pediatric Autologous Hematopoietic Stem Cell Transplantation: Safety, Efficacy, and Patient Outcomes. Literature Review
Anna Maria Testi, Maria Luisa Moleti, Alessia Angi, et al.
Pediatric Health Medicine and Therapeutics (2023) Vol. Volume 14, pp. 197-215
Open Access | Times Cited: 6
Selection of hematopoietic stem cell transplantation for T-cell lymphoblastic lymphoma
Zhen Li, Binglei Zhang, Xinxin Fan, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 6
The Future of Natural Killer Cell Immunotherapy for B Cell Non-Hodgkin Lymphoma (B Cell NHL)
Yaya Chu, Margaret Lamb, Mitchell S. Cairo, et al.
Current Treatment Options in Oncology (2022) Vol. 23, Iss. 3, pp. 381-403
Open Access | Times Cited: 9
Clinical Characteristics and Treatment Outcomes of Myeloid Sarcoma in Children: The Experience of the Polish Pediatric Leukemia and Lymphoma Study Group
Magdalena Samborska, Małgorzata Barańska, Jacek Wachowiak, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 8
Surveillance imaging in pediatric lymphoma
Stephan D. Voss, Mitchell S. Cairo
Pediatric Radiology (2019) Vol. 49, Iss. 11, pp. 1565-1573
Closed Access | Times Cited: 11
The New Treatment Methods for Non-Hodgkin Lymphoma in Pediatric Patients
Justyna Derebas, Kinga Panuciak, Mikołaj Margas, et al.
Cancers (2022) Vol. 14, Iss. 6, pp. 1569-1569
Open Access | Times Cited: 7
iTRAQ-Based Proteomic Analysis Reveals Potential Serum Biomarkers for Pediatric Non-Hodgkin’s Lymphoma
Runhong Yu, Linna Cheng, Shiwei Yang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 6
Management of Aggressive Non-Hodgkin Lymphomas in the Pediatric, Adolescent, and Young Adult Population: An Adult vs. Pediatric Perspective
Irtiza Sheikh, Amr Elgehiny, Dristhi Ragoonanan, et al.
Cancers (2022) Vol. 14, Iss. 12, pp. 2912-2912
Open Access | Times Cited: 6
Ibrutinib plus RICE or RVICI for relapsed/refractory mature B-cell non-Hodgkin lymphoma in children and young adults: SPARKLE trial
G. A. Amos Burke, Luciana Vinti, Edita Kabíčková, et al.
Blood Advances (2022) Vol. 7, Iss. 4, pp. 602-610
Open Access | Times Cited: 6
Immune checkpoint inhibitors therapy as the game-changing approach for pediatric lymphoma: A brief landscape
Sara Ebrahimi, Adrina Habibzadeh, Soroush Khojasteh-Kaffash, et al.
Critical Reviews in Oncology/Hematology (2023) Vol. 193, pp. 104225-104225
Closed Access | Times Cited: 3
Rituximab in the treatment of childhood mature B‐cell lymphoma: “Where do we go from here”
Mitchell S. Cairo
British Journal of Haematology (2019) Vol. 185, Iss. 6, pp. 1017-1020
Open Access | Times Cited: 8
Clinical characteristics and treatment outcomes of children and adolescents with aggressive mature B-cell lymphoma: a single-center analysis
Woojung Jeon, Young Kwon Koh, Sung Han Kang, et al.
Blood Research (2022) Vol. 57, Iss. 1, pp. 41-50
Open Access | Times Cited: 5
Safety and efficacy of combinatorial therapy utilizing myeloablative conditioning and autologous stem cell transplantation, targeted immunotherapy, and reduced intensity conditioning and allogeneic stem cell transplantation in children, adolescents, and young adults with relapsed/refractory mature B-cell non-Hodgkin lymphoma
Aliza Gardenswartz, Brinda Mehta, Nader Kim El‐Mallawany, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2022) Vol. 64, Iss. 1, pp. 234-237
Closed Access | Times Cited: 5
Cellular and humoral immunotherapy in children, adolescents and young adults with non-Hodgkin lymphoma
Yaya Chu, Aliza Gardenswartz, Caroline Diorio, et al.
Best Practice & Research Clinical Haematology (2023) Vol. 36, Iss. 1, pp. 101442-101442
Closed Access | Times Cited: 2
Reactive Lymphadenopathy in the Pediatric Population with a Focus on Potential Mimics of Lymphoma
R Mariani, Elizabeth L. Courville
Seminars in Diagnostic Pathology (2023) Vol. 40, Iss. 6, pp. 371-378
Closed Access | Times Cited: 2
Survival disparities between children and adolescents and young adults for the major subtypes of non-Hodgkin lymphoma in the Netherlands: a large population-based study
Maya Schulpen, Auke Beishuizen, Martine E.D. Chamuleau, et al.
Haematologica (2023) Vol. 109, Iss. 3, pp. 936-941
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top